\BOOKMARK [0][-]{appendix.A}{Sample Quality}{}% 171
\BOOKMARK [1][-]{section.A.1}{Sample Correlation}{appendix.A}% 172
\BOOKMARK [1][-]{section.A.2}{Replicate Samples in TCGA Breast}{appendix.A}% 173
\BOOKMARK [0][-]{appendix.B}{Software Used for Thesis}{}% 174
\BOOKMARK [0][-]{appendix.C}{Secondary Screen Data}{}% 175
\BOOKMARK [0][-]{appendix.D}{Mutation Analysis in Breast Cancer}{}% 176
\BOOKMARK [1][-]{section.D.1}{Synthetic Lethal Genes and Pathways}{appendix.D}% 177
\BOOKMARK [1][-]{section.D.2}{Comparison to Primary Screen}{appendix.D}% 178
\BOOKMARK [1][-]{section.D.3}{Resampling Analysis}{appendix.D}% 179
\BOOKMARK [1][-]{section.D.4}{Metagene Analysis}{appendix.D}% 180
\BOOKMARK [1][-]{section.D.5}{Mutation Variation}{appendix.D}% 181
\BOOKMARK [2][-]{subsection.D.5.1}{Mutation Frequency}{section.D.5}% 182
\BOOKMARK [2][-]{subsection.D.5.2}{PI3K Mutation Expression}{section.D.5}% 183
\BOOKMARK [1][-]{section.D.6}{Compare SLIPT genes}{appendix.D}% 184
\BOOKMARK [0][-]{appendix.E}{Expression Analysis in Stomach Cancer}{}% 185
\BOOKMARK [0][-]{appendix.F}{Mutation Analysis in Stomach Cancer}{}% 186
